Clin Mol Hepatol.
2023 Apr;29(2):394-397. 10.3350/cmh.2023.0104.
Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
- Affiliations
-
- 1Division of Gastroenterology, Ascension Providence Hospital, Michigan State University/College of Human Medicine, Southfield, MI, USA
- 2Houston Research Institute, Houston, TX, USA
- KMID: 2541426
- DOI: http://doi.org/10.3350/cmh.2023.0104
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future
- Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
- Imaging evaluation of non-alcoholic fatty liver disease: focused on quantification
- Diagnosis of Non-alcoholic Fatty Liver Disease
- Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions
